Page last updated: 2024-08-22

platinum and ifosfamide

platinum has been researched along with ifosfamide in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (30.77)18.2507
2000's4 (30.77)29.6817
2010's2 (15.38)24.3611
2020's3 (23.08)2.80

Authors

AuthorsStudies
Almadrones, L; Hakes, T; Hoskins, W; Jones, W; Lewis, JL; Markman, M; Pizzuto, F; Reichman, B; Rubin, S1
Cabanillas, FC; Hagemeister, FB; McLaughlin, P; Rodriguez, MA; Romaguera, JE; Swan, F; Velasquez, W1
De Ruysscher, D; Demedts, M; Spaas, P; Specenier, P; Van den Brande, P; Vansteenkiste, J1
Coosemans, W; De Leyn, P; Deneffe, G; Lerut, T; Van Raemdonck, D; Vansteenkiste, J1
Comerci, JT; Edwards, RP; Kanbour-Shakir, A; Kelley, JL; Kunschner, AJ; Price, FV; Sit, AS1
Minoia, C; Ronchi, A; Sottani, C; Turci, R1
Dorey, F; Eckardt, J; Eilber, FC; Eilber, FR; Nelson, SD; Rosen, G; Selch, M1
Brunetti, C; Cassano, G; Colucci, G; Galetta, D; Gebbia, V; Germano, D; Giampaglia, M; Guida, M; Izzi, G; Lorusso, V; Nettis, G; Silvestris, N; Spada, M1
Abedallaa, N; Baey, C; Besse, B; de Montpreville, VT; Fabre, D; Guigay, J; Pechoux, CL; Pignon, JP; Planchard, D; Soria, JC; Tremblay, L1
Dong, M; Gui, L; He, X; Hu, S; Jia, B; Liu, P; Qin, Y; Yang, J; Yang, S; Zhang, C; Zhou, S1
Adorni, M; Bazzurini, L; Buda, A; Grassi, T; Landoni, F; Lissoni, AA; Negri, S; Vecchione, F1
Chang, WH; Chen, YJ; Huang, HY; Lee, NR; Lin, SC; Su, MH; Wang, PH; Wu, HH1
Kimura, T; Kurita, T; Miyoshi, AI; Ueda, Y; Yoshino, K1

Reviews

1 review(s) available for platinum and ifosfamide

ArticleYear
Recent Advances in the Management of Small Cell Carcinoma of the Uterine Cervix.
    Anticancer research, 2023, Volume: 43, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Carcinoma, Small Cell; Cervix Uteri; Cisplatin; Etoposide; Female; Humans; Ifosfamide; Lung Neoplasms; Neoplasm Staging; Platinum; Rare Diseases; Small Cell Lung Carcinoma; Uterine Cervical Neoplasms

2023

Trials

5 trial(s) available for platinum and ifosfamide

ArticleYear
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:2

    Topics: Acute Kidney Injury; Adult; Aged; Carcinoma; Drug Evaluation; Drug Resistance; Female; Humans; Ifosfamide; Mesna; Middle Aged; Ovarian Neoplasms; Platinum

1992
A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Mesna; Middle Aged; Mitoxantrone; Platinum; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Treatment Failure

1995
Sequential treatment with vindesine-ifosfamide-platinum (VIP) chemotherapy followed by platinum sensitized radiotherapy in stage IIIB non-small cell lung cancer: a phase II trial.
    Lung cancer (Amsterdam, Netherlands), 1998, Volume: 22, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Drug Administration Schedule; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Platinum; Prospective Studies; Radiation-Sensitizing Agents; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vindesine

1998
Result of induction chemotherapy followed by surgery in patients with stage IIIA N2 NSCLC: importance of pre-treatment mediastinoscopy.
    European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 1999, Volume: 15, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Ifosfamide; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinoscopy; Middle Aged; Neoplasm Staging; Platinum; Pneumonectomy; Prognosis; Prospective Studies; Remission Induction; Survival Analysis; Survival Rate; Vindesine

1999
Topotecan plus ifosfamide in patients with platinum refractory advanced/metastatic non-small cell lung cancer: a phase II trial.
    Oncology reports, 2005, Volume: 14, Issue:6

    Topics: Adult; Aged; Alopecia; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Drug Resistance, Neoplasm; Female; Humans; Ifosfamide; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Neutropenia; Platinum; Thrombocytopenia; Topotecan; Treatment Outcome

2005

Other Studies

7 other study(ies) available for platinum and ifosfamide

ArticleYear
Chemotherapy for malignant mixed Müllerian tumors of the ovary.
    Gynecologic oncology, 2000, Volume: 79, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Middle Aged; Mixed Tumor, Mullerian; Neoplasm Staging; Ovarian Neoplasms; Paclitaxel; Platinum; Retrospective Studies; Survival Analysis; Taxoids; Treatment Outcome

2000
Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents.
    Toxicology letters, 2002, Aug-05, Volume: 134, Issue:1-3

    Topics: Adult; Antineoplastic Agents, Alkylating; Chromatography, High Pressure Liquid; Cyclophosphamide; Environmental Monitoring; Female; Humans; Ifosfamide; Male; Mass Spectrometry; Methotrexate; Occupational Exposure; Personnel, Hospital; Platinum; Sensitivity and Specificity

2002
High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality.
    Annals of surgery, 2003, Volume: 237, Issue:2

    Topics: Amputation, Surgical; Antineoplastic Agents; Antineoplastic Protocols; Combined Modality Therapy; Doxorubicin; Extremities; Female; Humans; Ifosfamide; Limb Salvage; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Platinum; Prognosis; Radiotherapy; Risk Factors; Sarcoma; Survival Analysis; Treatment Outcome

2003
Effect of chemotherapy in patients with resected small-cell or large-cell neuroendocrine carcinoma.
    Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2012, Volume: 7, Issue:7

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Neuroendocrine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lung Neoplasms; Lymph Nodes; Male; Methotrexate; Middle Aged; Neoplasm Staging; Perioperative Care; Platinum; Pneumonectomy; Prognosis; Retrospective Studies; Small Cell Lung Carcinoma; Survival Rate

2012
[Efficacy and safety evaluation of gemcitabine combined with ifosfamide in patients with advanced nasopharyngeal carcinoma after failure of platinum-based chemotherapy].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2015, Volume: 37, Issue:8

    Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Deoxycytidine; Disease-Free Survival; Gemcitabine; Humans; Ifosfamide; Induction Chemotherapy; Kaplan-Meier Estimate; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neutropenia; Platinum; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Failure

2015
Neoadjuvant chemotherapy followed by radical surgery in locally advanced vulvar carcinoma: a single-institution experience.
    Tumori, 2022, Volume: 108, Issue:5

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Humans; Ifosfamide; Neoadjuvant Therapy; Neoplasm Staging; Paclitaxel; Platinum; Retrospective Studies; Uterine Cervical Neoplasms; Vulvar Neoplasms

2022
Comparing paclitaxel-platinum with ifosfamide-platinum as the front-line chemotherapy for patients with advanced-stage uterine carcinosarcoma.
    Journal of the Chinese Medical Association : JCMA, 2022, 02-01, Volume: 85, Issue:2

    Topics: Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Female; Humans; Ifosfamide; Middle Aged; Paclitaxel; Platinum; Postoperative Period; Retrospective Studies; Uterine Neoplasms

2022